Your browser doesn't support javascript.
loading
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival.
García-Sanz, Ramón; Dogliotti, Irene; Zaccaria, Gian Maria; Ocio, Enrique María; Rubio, Araceli; Murillo, Ilda; Escalante, Fernando; Aguilera, Carmen; García-Mateo, Aránzazu; García de Coca, Alfonso; Hernández, Roberto; Dávila, Julio; Puig, Noemí; García-Álvarez, María; Chillón, María Del Carmen; Alcoceba, Miguel; Medina, Alejandro; González de la Calle, Verónica; Sarasquete, María Eugenia; González, Marcos; Gutiérrez, Norma Carmen; Jiménez, Cristina.
Afiliação
  • García-Sanz R; Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Dogliotti I; Unit of Haematology, Department of Biotechnology & Health Sciences, University of Torino, Torino, Italy.
  • Zaccaria GM; Unit of Haematology, Department of Biotechnology & Health Sciences, University of Torino, Torino, Italy.
  • Ocio EM; Haematology Department, University Hospital of Marqués de Valdecilla, Santander, Spain.
  • Rubio A; Haematology Department, Miguel Servet Hospital, Zaragoza, Spain.
  • Murillo I; Haematology Department, Miguel Servet Hospital, Zaragoza, Spain.
  • Escalante F; Haematology Department, Hospital Complex of León, León, Spain.
  • Aguilera C; Haematology Department, Regional Hospital of El Bierzo, León, Spain.
  • García-Mateo A; Haematology Department, General Hospital of Segovia, Segovia, Spain.
  • García de Coca A; Haematology Department, University Clinical Hospital of Valladolid, Valladolid, Spain.
  • Hernández R; Haematology Department, Virgen de la Concha Hospital, Zamora, Spain.
  • Dávila J; Haematology Department, Nuestra Señora de Sonsoles Hospital, Ávila, Spain.
  • Puig N; Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • García-Álvarez M; Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Chillón MDC; Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Alcoceba M; Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Medina A; Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • González de la Calle V; Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Sarasquete ME; Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • González M; Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Gutiérrez NC; Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Jiménez C; Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
Br J Haematol ; 192(5): 843-852, 2021 03.
Article em En | MEDLINE | ID: mdl-32780894
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Macroglobulinemia de Waldenstrom Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Macroglobulinemia de Waldenstrom Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article